An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for EXACT SCIENCES Corp
| Ticker | EXAS |
| FIGI | BBG000CWL0F5 |
| CUSIP | 30063P105 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 510 / 7.3% |
| Percentage held by institutional investors | 100.0% |
About
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. Wikipedia